It has been demonstrated that increased levels of IL-6 from 6 hours until ≥18 days post-COVID-19 symptom onset, is associated with poor prognosis (30, 132), whereas its gradual increase within 3-5 days, and its return to normal levels after 15-17 days, is linked to good prognosis (132). This evidence concerns the gene IL6 and COVID-19.